The director of the FDA's main drug review office will exit on Jan. 18, according to an email sent to staff. Her departure is ...

Following a string of FDA resignations, Patrizia Cavazzoni has announced that her last day will be 18 January.

Patrizia Cavazzoni, leader of the FDA's Center for Drug Evaluation and Research, is leaving the agency on Jan. 18.

The FDA’s influential director of the Center for Drug Evaluation and Research, Patrizia Cavazzoni, M.D., will soon retire ...

FDA's Center for Drug Evaluation and Research director, Patrizia Cavazzoni, MD, to step down in mid-January. Other top leaders also leaving FDA.

It’s the second time in less than a month that retailer has recalled the medication; this time due to a potential foreign ...

It will be co-led by Patrizia Cavazzoni, director of the FDA's Centre for Drugs Evaluation and Research (CDER), and Centre for Biologics Evaluation and Research (CBER) director Peter Marks.

According to CDER Director Patrizia Cavazzoni, CDER’s new Center for Real-World Evidence Innovation represents a major step ...

this treatment option is the first therapy to target and affect the underlying disease process of Alzheimer's," said Patrizia Cavazzoni, head of the FDA's Center for Drug Evaluation and Research ...

The FDA guidance caps lead levels for children younger than 2 at 10 parts per billion for fruits, most vegetables, grain and meat mixtures, yogurts, custards and puddings, and single-ingredient meats.

Recognizing the increased use of artificial intelligence in the development of new therapies, the U.S. FDA on Monday released separate draft guidance on the use of the technology in the ...

Former commissioner of the Food and Drug Administration (FDA) Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security Council ...